Tacrolimus 0.1% In Pseudocatalase
FDA Label NDC 72934-2174
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sincerus Florida, Llc for the product Tacrolimus 0.1% In Pseudocatalase (NDC 72934-2174). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding directions for use, sincerus florida, llc adverse reactions., active, inactive, ndc 72934-2174-2 / tacrolimus usp 0.1%. cream 30gm, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
